|
|
|
Volumn 16, Issue 9 Suppl 9, 2002, Pages 19-24
|
|
Targeted therapy in non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ENDOTHELIAL CELL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
LYMPHOKINE;
MONOCLONAL ANTIBODY;
PROTEIN KINASE C;
SIGNAL PEPTIDE;
VASCULOTROPIN;
VASCULOTROPIN A;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
ENDOTHELIAL GROWTH FACTORS;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
LUNG NEOPLASMS;
LYMPHOKINES;
PROTEIN KINASE C;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0036728845
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (23)
|
|
References (22)
|
